|
مجال التميز |
تميز دراسي و بحثي |
|
|
|
|
البحوث المنشورة |
|
|
البحث (1): |
|
|
عنوان البحث: |
NG28: Promoting Patient-Centred Care For Adults With Type 2 Diabetes |
|
رابط إلى البحث: |
|
|
تاريخ النشر: |
12/05/2016 |
|
موجز عن البحث: |
Diabetes mellitus, usually classified as either type 1 (T1DM) or type 2 (T2DM), is a long-term metabolic disorder, characterised by a chronically elevated blood glucose level (hyperglycaemia), which results from defects in insulin secretion, insulin action, or both (Kumar et al, 2003). The number of people with diabetes has quadrupled since 1980, to 422 million (World Health Organization, 2016), and the condition is now one of the biggest threats to human health in the 21st century (Zimmet et al, 2005). Over the past two decades, there has been an explosive increase in the number of people diagnosed with diabetes worldwide (International Diabetes Federation, 2015). Changes in the human environment and a tendency towards an obesogenic lifestyle, together with globalisation, have resulted in alarming rises in the rates of both obesity and diabetes. It is estimated that the NHS spends 10% of its budget on diabetes (Hex, 2012); the total cost (direct care and indirect costs) associated with diabetes in the UK currently stands at £23.7 billion, and this figure is predicted to rise to £39.8 billion by 2035/6 (Hex, 2016). In December 2015, the National Institute for Health and Care Excellence (NICE) published a new guideline, NG28, Type 2 diabetes in adults: Management, which gives recommendations for managing the condition, with a focus on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications. This article gives a critical overview of the new guideline. |
|
البحث (2): |
|
|
عنوان البحث: |
Pharmacological Options For Managing Type 2 Diabetes |
|
رابط إلى البحث: |
|
|
تاريخ النشر: |
09/07/2016 |
|
موجز عن البحث: |
Diabetes, a chronic progressive life-long metabolic disorder, is characterised by hyperglycaemia, which is due mainly to absolute (type 1 diabetes) or relative (type 2 diabetes) insulin deficiency. The disease is fast-emerging as one of the world’s biggest health catastrophes. In the UK, as elsewhere in the world, the prevalence of this long-term disorder is escalating in an uncontrollable manner. A more concerted, strategic and multi-sectorial policy approach, underpinned by solid research, is essential to improving human behaviour and lifestyle to reverse the negative trends in the global incidence of this condition. The management of this condition is becoming a significant health-care challenge to health professionals. Various pharmacological options, such as oral hypoglycaemic agents and subcutaneous insulin, are now available for glycaemic control. Health professionals should always give serious consideration to structured education to help people with diabetes to adhere to their regimen. In turn, this education will improve people’s quality of life by minimising and/or slowing the development of diabetes-related complications. |
